Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 2:02 PM UTC
| NCT Number | NCT06580314 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | PHASE3 |
| Target Enrollment | 880 participants |
| Active Locations | 676 sites in the US |
| Sponsor | NRG Oncology |
| Last Updated on CT.gov | August 7, 2026 (3 weeks ago) |
As of August 31, 2026: Clinical trial NCT06580314 is currently recruiting participants. This phase3 study for ovarian cancer is actively seeking new participants at 676 locations across the United States. The study is sponsored by NRG Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06580314 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 676 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06580314 was last updated 3 weeks ago (August 7, 2026). HelloStudys verifies this status automatically.